DWP
RVNC
Daymark Wealth Partners’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-15,000
| Closed | -$77.9K | – | 530 |
|
|
2024
Q3 | $77.9K | Sell |
15,000
-61,000
| -80% | -$317K | ﹤0.01% | 508 |
|
|
2024
Q2 | $195K | Buy |
76,000
+30,000
| +65% | +$77.1K | 0.01% | 486 |
|
|
2024
Q1 | $226K | Buy |
46,000
+17,000
| +59% | +$83.6K | 0.01% | 395 |
|
|
2023
Q4 | $255K | Buy |
29,000
+5,000
| +21% | +$44K | 0.02% | 344 |
|
|
2023
Q3 | $275K | Buy |
24,000
+10,000
| +71% | +$115K | 0.02% | 319 |
|
|
2023
Q2 | $354K | Buy |
+14,000
| New | +$354K | 0.03% | 279 |
|